Michaela Fleming

Michael K. Gusmano, PhD, discusses the importance of maintaining ethical standards in research evaluating potential therapeutics and vaccines for COVID-19.

Hollis O’Neal, MD, the national primary investigator for the Cytovale early sepsis detection system, discusses sepsis and COVID-19 and provides an overview of his pilot study.

Previous research has suggested an association between bacteria from the Bovis group streptococci, Clostridium septicum and colorectal cancer

In part 2 of the interview, Ryan W. Stevens, PharmD, BCIDP, discusses the risks associated with convalescent plasma and highlights what clinicians should know.

In part 1 of our interview, Ryan W. Stevens, PharmD, BCIDP, provides an overview of how convalescent plasma has been used to treat infectious diseases including coronaviruses.

Stay up to date on the latest coronavirus news from Friday, April 24th.

MenQuadfi is the only FDA approved quadrivalent meningococcal vaccine that is indicated for individuals 2 through 56 years of age and older.

Stay up to date on the latest coronavirus updates from Thursday, April 23rd.

This test, which will be marketed throughout the United States, can instantly detect antibodies in whole blood, serum, and plasma for SARS-CoV-2.

Investigators have hypothesized that scarlet fever transmission is driven by pediatric cases with symptomatic disease.

A new survey found that parents in Spain were the most supportive of vaccinations when compared with their counterparts in 4 other European countries.

This test kit was developed to both increase the supply of COVID-19 tests for first responders and frontline health care workers who develop symptoms of COVID-19.

Lucas Schulz, PharmD, BCPS, AQ-ID, discusses how he is preparing for COVID-19 as a clinical pharmacist working in Wisconsin.

Stay up to date with the latest COVID-19 news from Friday, April 17th.

Rebecca Dutch, PhD, discusses misconceptions about the SARS-CoV-2 virus, how the virus differs from other coronaviruses, and critical information that remains unknown.

Stay up to date on the latest COVID-19 news from Thursday, April 16, 2020.

Jeannette Bouchard, PharmD, discusses how ID pharmacists are taking on new responsibilities and working collaboratively to respond to COVID-19.

Stay up to date on the latest coronavirus updates from April 15th.

The study has not been peer-reviewed yet, but the findings have been released to assist the public in responding to COVID-19.

Stay up to date on the latest coronavirus updates from April 14th.

Ramy Elshaboury, PharmD, BCPS, AQ ID, discusses the process of putting COVID-19 guidance in place using currently available literature and data.

Thomas Dilworth, PharmD, shares tips and resources that can help busy clinicians stay engaged and up to date during the COVID-19 pandemic.

Matthew Davis, PharmD, provides an overview on the agent remdesivir.

Check out the latest coronavirus updates from Friday, April 10th.

The emergency use authorization will support the decontamination of 750,000 N95 respirators per day in the United States

Thomas Dilworth, PharmD, provides a recap of ACEIs, ARBs, and NSAIDs in patients with COVID-19.

The system can be used among adult patients with COVID-19 who have been admitted to the ICU and are currently experiencing or will experience respiratory failure.

Check out the latest coronavirus updates from Thursday, April 9th.

The trial will evaluate the safety and effectiveness of the agent in adults who are hospitalized with the novel virus

Krutika N. Mediwala, PharmD, BCPS, BCIDP, provides a recap of available information regarding Kaletra for the treatment of COVID-19.